Ever since the little blue pill, viagra, hit the American market, replica male sexual enhancement products have been televised and nationally advertised. Late ngiht television is bombarded with these sexual ads for male enhancement products and now women are included in this lucrative market.

Forbes publication reports that women get equal access to the vitality of sexual enhancement with  a safe, proven and tested affordable product. The female counterpart to Viagra that is available to legal age participants is called Zestra.

Zestra is a topical potion or ointment meaning that the sexual enhancement product is not taken orally but used externally as an  application. Zestra is made from evening primrose and borge oils with two extracts.  These products are all natural ingredients. Zestra exhance and stimulate sexual erousal in women as the little blue pill, viagra, stimulates men.

Zestra laboratories initially was manufactured in Charleston, South Carolina and was valued at about $35 milion. The company did not fair too well in 2008 because of expensive prime time advertising campaigns and subsequent expensive patented commissioned research. Zestra Labs had hoped to give credibility to the sexual enhancement product with medical professional endorsements.

The research and development presently state that Zestra performed better than a placebo and increased desire, arousal and sexual satisfaction in seven out of ten women. Zestra was carried by Walgreen, CVS, Walmart and Kmart stores as an over the counter preparation. However, these retail locations charged Zestra Labs a costly placement fee to maintain selling space on their store shelves.

Zestra Labs continued to have legal problems and filed Chapter 11 in 2008 much like the Chrysler and General Motors companies. As these major companies did not fold neither did Zestra. Consultants who supported Advil came to Zestra's financial rescue.

The consultants discovered that a gender gap existed with the women enhancement product market. Men spent $6 billion a year on sexual enhancement products but women only outlay to the industry was $200 million according to verifiable financial data. Through a resell and business restructuring, Zestra re-emerged as Semprae. The new company moved from Charleston, South Carolina to Saddle Brook, New Jersey.   Also research to appeal to women's sexuality to gain support for the sexual enhancement product, Zestra.

Later and more recent research by new owners and research reports proved that women did in fact want a product to improve their sexual lives.  After the renewed research, Semprae's scent was modified from earthy to a scentless sexual enhancement attractive aroma. Research costing over $200,000 saw the cost effectiveness of changing the orange and purple package to a more subdued color that packaging emphasized the natural ingredients of Zestra. Advertising was targeted from the pharmacies to televison shows such as Soapnet and Discovery Health which are nationally syndicated programs.

Semprae formerly marketed as Zestra and  still marketed as an original, the female sexual enhancement ointment or potion, is now sold at about 4,000 markets. The new product, Semprae is now carried at Walmart and Target and is available online though Amazon.com.

Zestra hit markets again in May of 2009 selling in three to nine mililiter packets of one usage each. Gynecologists are recommending the product, Zestra to their patients experiencing low sex drives. Users have provided testimony of increased sexual arousal after using the sexual enhancement, Zestra as reported by Forbes publication.

Zestra is constantly raising awareness to doctors of its credibility as reported by medical journals to the medical community. For more information about the female sexual enhancement ointment, Zestra, refer to the Journal of Sex & Marital Therapy in its upcoming September 2009 publication.